Key result
Upper extremity deep vein thrombosis showed no significant difference in the prevalence of prothrombotic markers compared to lower limb deep vein thrombosis, though females with UEDVT had higher marker prevalence (P=0.046).
Observational (n=289)
No
The topology and etiological factors of deep vein thrombosis in Indian patients differ by sex and from Western populations, with higher prothrombotic marker prevalence in females with UEDVT.
We assessed the clinical manifestations in upper and lower limb deep venous thrombosis patients from India and difference in etiological factors. Fifty-three patients with primary upper extremity deep vein thrombosis (UEDVT; males 30, females 23) and 236 patients with lower limb deep vein thrombosis (LLDVT; males 157, females 79) were included in this study. The thrombophilia markers studied were protein C (PC), protein S (PS), antithrombin (AT) III, and factor V Leiden (FVL) mutation. Females had significantly higher prevalence of prothrombotic markers as compared to males (P = .046) in the UEDVT group. No statistically significant differences in the prevalence of prothrombotic markers were observed between the LLDVT and the UEDVT patients. The clinical picture however revealed greater involvement of thrombus of the iliofemoral vein (P = .009) and the proximal tibial vein (P = .005) in males than females, while no differences were observed in the clinical manifestations between the 2 sexes in UEDVT patients. Our study is able to give a broad perspective of the prevalence data of UEDVT and LLDVT in the city of Mumbai of approximately 5 million population served by this hospital. We conclude that the topology of thrombosis in deep vein thrombosis (DVT) patients in India is different from that of the Western countries.
No takes yet. Share an insight, caveat, or question.
Pai et al. (2009) conducted an observational in Deep venous thrombosis (upper extremity and lower limb) (n=289). Upper extremity deep vein thrombosis (UEDVT) vs. Lower limb deep vein thrombosis (LLDVT) was evaluated on Prevalence of prothrombotic markers (protein C, protein S, antithrombin III, and factor V Leiden mutation). Upper extremity deep vein thrombosis showed no significant difference in the prevalence of prothrombotic markers compared to lower limb deep vein thrombosis, though females with UEDVT had higher marker prevalence (P=0.046).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: